Description
A neuropeptide that is an agonist of NPSR (EC50 = 3.2 nM); increases the duration of wakefulness and decreases SWS1, SWS2, and REM sleep in rats; dose-dependently (0.5-4 nmol per animal, i.c.v.) decreases fecal pellet excretion induced by restraint stress or CRF; nasal administration inhibits audible and ultrasonic vocalizations and has anxiolytic-like effects in the elevated plus-maze test in a mouse model of arthritis
Formal name: L-seryl-L-phenylalanyl-L-arginyl-L-asparaginylglycyl-L-valylglycyl-L-serylglycyl-L-valyl-L-lysyl-L-lysyl-L-threonyl-L-seryl-L-phenylalanyl-L-arginyl-L-arginyl-L-alanyl-L-lysyl-L-glutamine
Synonyms: NPS
Molecular weight: 2,210.50
CAS: 412938-75-1
Purity: ≥95%
Formulation: A lyophilized powder
Product Type|Biochemicals|Peptides|Neuropeptides||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Glucocorticoids & Mineralocorticoids||Research Area|Neuroscience|Behavioral Neuroscience|Anxiety||Research Area|Neuroscience|Behavioral Neuroscience|Sleep & Biological Rhythms